Hepcidin and Iron in Health and Disease

Abstract

Hepcidin, the iron-regulatory hormone, determines plasma iron concentrations and total body iron content. Hepcidin, secreted by hepatocytes, functions by controlling the activity of the cellular iron exporter ferroportin, which delivers iron to plasma from intestinal iron absorption and from iron stores. Hepcidin concentration in plasma is increased by iron loading and inflammation and is suppressed by erythropoietic stimulation and during pregnancy. Hepcidin deficiency causes iron overload in hemochromatosis and anemias with ineffective erythropoiesis. Hepcidin excess causes iron-restrictive anemias including anemia of inflammation. The development of hepcidin diagnostics and therapeutic agonists and antagonists should improve the treatment of iron disorders.

References 86

1. 1.

   Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW 2021. Iron deficiency. Lancet 397:233–48

   Not in our library10.1016/s0140-6736(20)32594-0

2. 2.

   Pantopoulos K 2018. Inherited disorders of iron overload. Front. Nutr 5:103

   Not in our library10.3389/fnut.2018.00103

3. 3.

   Park CH, Valore EV, Waring AJ, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem 276:7806–10

   Not in our library10.1074/jbc.m008922200

4. 4.

   Sangkhae V, Nemeth E. 2017. Regulation of the iron homeostatic hormone hepcidin. Adv. Nutr 8:126–36

   Not in our library10.3945/an.116.013961

5. 5.

   Ganz T, Nemeth E. 2011. Hepcidin and disorders of iron metabolism. Annu. Rev. Med 62:347–60

   Not in our library10.1146/annurev-med-050109-142444

6. 6.

   Kautz L, Jung G, Valore EV, 2014. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat. Genet 46:678–84

   Not in our library10.1038/ng.2996

7. 7.

   Sangkhae V, Fisher AL, Chua KJ, 2020. Maternal hepcidin determines embryo iron homeostasis in mice. Blood 136:2206–16

   Not in our library10.1182/blood.2020005745

8. 8.

   Nemeth E, Rivera S, Gabayan V, 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Investig 113:1271–76

   Not in our library10.1172/jci20945

9. 9.

   Stefanova D, Raychev A, Arezes J, 2017. Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. Blood 130:245–57

   Not in our library10.1182/blood-2017-03-772715

10. 10.
    An essential cell-autonomous role for hepcidin in cardiac iron homeostasis · 2016

    No notice
11. 11.

    Malerba M, Louis S, Cuvellier S, 2020. Epidermal hepcidin is required for neutrophil response to bacterial infection. J. Clin. Investig 130:329–34

    Not in our library10.1172/jci126645

12. 12.

    Bessman NJ, Mathieu JRR, Renassia C, 2020. Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing. Science 368:186–89

    Not in our library10.1126/science.aau6481

13. 13.

    Donovan A, Lima CA, Pinkus JL, 2005. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1:191–200

    Not in our library10.1016/j.cmet.2005.01.003

14. 14.

    Taniguchi R, Kato HE, Font J, 2015. Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin. Nat. Commun 6:8545

    Not in our library10.1038/ncomms9545

15. 15.

    Zhang DL, Ghosh MC, Ollivierre H, 2018. Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress. Blood 132:2078–87

    Not in our library10.1182/blood-2018-04-842997

16. 16.

    Aschemeyer S, Qiao B, Stefanova D, 2018. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood 131:899–910

    Not in our library10.1182/blood-2017-05-786590

17. 17.

    Qiao B, Sugianto P, Fung E, 2012. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 15:918–24

    Not in our library10.1016/j.cmet.2012.03.018

18. 18.

    Nemeth E, Tuttle MS, Powelson J, 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–93

    Not in our library10.1126/science.1104742

19. 19.

    Billesbolle CB, Azumaya CM, Kretsch RC, 2020. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature 586:807–11

    Not in our library10.1038/s41586-020-2668-z

20. 20.

    Preza GC, Ruchala P, Pinon R, 2011. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J. Clin. Investig 121:4880–88

    Not in our library10.1172/jci57693

21. 21.

    Schwartz AJ, Das NK, Ramakrishnan SK, 2019. Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload. J. Clin. Investig 129:336–48

    Not in our library10.1172/jci122359

22. 22.

    Fisher AL, Babitt JL. 2022. Coordination of iron homeostasis by bone morphogenetic proteins: current understanding and unanswered questions. Dev. Dyn 251:26–46

    Not in our library10.1002/dvdy.372

23. 23.

    Silvestri L, Nai A, Dulja A, Pagani A. 2019. Hepcidin and the BMP-SMAD pathway: an unexpected liaison. Vitam. Horm 110:71–99

    Not in our library10.1016/bs.vh.2019.01.004

24. 24.

    Canali S, Zumbrennen-Bullough KB, Core AB, 2017. Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice. Blood 129:405–14

    Not in our library10.1182/blood-2016-06-721571

25. 25.

    Canali S, Wang CY, Zumbrennen-Bullough KB, 2017. Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6. Am. J. Hematol 92:1204–13

    Not in our library10.1002/ajh.24888

26. 26.

    Kautz L, Meynard D, Monnier A, 2008. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112:1503–9

    Not in our library10.1182/blood-2008-03-143354

27. 27.

    Kautz L, Jung G, Du X, 2015. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia. Blood 126:2031–37

    Not in our library10.1182/blood-2015-07-658419

28. 28.

    Wang CY, Xu Y, Traeger L, 2020. Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3. Blood 135:453–56

    Not in our library10.1182/blood.2019002620

29. 29.

    Artuso I, Pettinato M, Nai A, 2019. Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice. Haematologica 104:e87–90

    Not in our library10.3324/haematol.2018.199810

30. 30.

    Gonzalez-Fernandez D, Nemeth E, Pons EDC, 2021. INTERGROWTH-21 identifies high prevalence of low symphysis-fundal height in indigenous pregnant women experiencing multiple infections, nutrient deficiencies, and inflammation: the Maternal Infections, Nutrient Deficiencies, and Inflammation (MINDI) cohort. Curr. Dev. Nutr 5:nzab012

    Not in our library10.1093/cdn/nzab012

31. 31.

    Armitage AE, Eddowes LA, Gileadi U, 2011. Hepcidin regulation by innate immune and infectious stimuli. Blood 118:4129–39

    Not in our library10.1182/blood-2011-04-351957

32. 32.

    Kim A, Fung E, Parikh SG, 2014. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 123:1129–36

    Not in our library10.1182/blood-2013-08-521419

33. 33.

    Ganz T 2019. Anemia ofinflammation. N. Engl. J. Med 381:1148–57

    Not in our library10.1056/nejmra1804281

34. 34.

    Peters HP, Laarakkers CM, Pickkers P, 2013. Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol. 14:70

    Not in our library10.1186/1471-2369-14-70

35. 35.

    Zaritsky J, Young B, Gales B, 2010. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin. J. Am. Soc. Nephrol 5:1010–14

    Not in our library10.2215/cjn.08161109

36. 36.

    Anderson GJ, Bardou-Jacquet E. 2021. Revisiting hemochromatosis: genetic versus phenotypic manifestations. Ann. Transl. Med 9:731

    Not in our library10.21037/atm-20-5512

37. 37.

    Knutson MD. 2019. Non-transferrin-bound iron transporters. Free Radic. Biol. Med 133:101–11

    Not in our library10.1016/j.freeradbiomed.2018.10.413

38. 38.

    Cooray SD, Heerasing NM, Selkrig LA, 2018. Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report. J. Med. Case Rep 12:18

    Not in our library10.1186/s13256-017-1526-6

39. 39.

    Girelli D, Trombini P, Busti F, 2011. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica 96:500–6

    Not in our library10.3324/haematol.2010.033449

40. 40.

    Girelli D, Busti F, Brissot P, 2022. Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood 139:3018–29

    Not in our library10.1182/blood.2021011338

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.